Search

Author/Creator Hanaford, Allison

3. FSMP-18. COMPREHENSIVE METABOLIC PROFILING OF HIGH MYC MEDULLOBLASTOMA REVEALS KEY DIFFERENCES BETWEEN IN VITRO AND IN VIVO GLUCOSE AND GLUTAMINE USAGE. (25th March 2021)

Authors:
Pham, Khoa; Poore, Brad; Hanaford, Allison; Maxwell, Micah J; Sweeney, Heather; Parthasarathy, Akhila; Alt, Jesse; Rais, Rana; Slusher, Barbara S; Eberhart, Charles G; Raabe, Eric H
Journal:
Neuro-oncology advances
Issue:
Volume 3(2021)Supplement 1
Page Start:
i19
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Inhibition of enhancer of zest homologue 2 is a potential therapeutic target for high‐MYC medulloblastoma. Issue 2 (10th January 2019)

Authors:
Natsumeda, Manabu; Liu, Yang; Nakata, Satoshi; Miyahara, Hiroaki; Hanaford, Allison; Ahsan, Sama; Stearns, Duncan; Skuli, Nicolas; Kahlert, Ulf D.; Raabe, Eric H.; Rodriguez, Fausto J.; Eberhart, Charles G.
Journal:
Neuropathology
Issue:
Volume 39:Issue 2(2019)
Page Start:
71
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. OTME-9. Comprehensive Metabolic Profiling Of high MYC Medulloblastoma Reveals Key Differences Between In Vitro And In Vivo Glucose And Glutamine Usage. (5th July 2021)

Authors:
Pham, Khoa; Poore, Brad; Hanaford, Allison; Maxwell, Micah J; Sweeney, Heather; Parthasarathy, Akhila; Alt, Jesse; Rais, Rana; Slusher, Barbara S; Eberhart, Charles G; Raabe, Eric H
Journal:
Neuro-oncology advances
Issue:
Volume 3(2021)Supplement 2
Page Start:
ii15
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗